Pregnancy outcome following first-trimester exposure to zopiclone: A prospective controlled cohort study

American Journal of Perinatology

Volumn 16, Issue 4, 1999, Pages 157-160

  Diav Citrin, Orna ^a   Okotore, Bunmi ^b   Lucarelli, Kristen ^b   Koren, Gideon ^b  

^a HEBREW UNIVERSITY   (Israel)

^b NONE

Author keywords

Human pregnancy; Insomnia; Zopiclone

Indexed keywords

BENZODIAZEPINE; HYPNOTIC AGENT; ZOPICLONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; EMBRYO DEVELOPMENT; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LOW BIRTH WEIGHT; ORAL DRUG ADMINISTRATION; PERINATAL DRUG EXPOSURE; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PRIORITY JOURNAL; TERATOGENESIS;

EID: 0032797261     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993850     Document Type: Article

References (10)

1. Imovane®. Product Monograph. Montréal, Quebec, Canada: Rhône-Poulenc Rorer
2. Fernandez C, Martin C, Gimenez F, Farinotti R. Clinical pharmacokinetics of zopiclone. Clin Pharmacokinet 1995;29:431-441
3. Noble S, Langtry HD, Lamb HM. Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia. Drugs 1988; 55:277-302
4. Lader M. Zopiclone: Is there any dependence and abuse potential? J Neurol 1997;244(Suppl. 1):S18-S22
5. Esaki K, Umemura T, Yamaguchi K, Takada K, Yanagita T. Reproduction studies of zopiclone in rats. Jitchken Zenrinsho Kenkyuho 1983;9:127-144
6. Tanioka Y, Koizumi H, Shibuya A. Teratogenicity study of zopiclone in crab-eating monkeys. Jitchken Zenrinsho Kenkyuho 1983;9:157-174
7. Arbuckle T, Wilkins R, Sherman G. Birth weight percentiles by gestational age in Canada. Obstet Gynecol 1993;81:39-41
8. Zax M, Sameroff AJ, Babigian HM. Birth outcomes in the offspring of mentally disordered women. Am J Orthopsychiatry 1977;47:218-230
9. Orr ST, Miller CA. Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiol Rev 1995;17:165-171
10. Krogh CME, ed. Compendium of Pharmaceuticals and Specialties, 33rd ed. Ottawa: Canadian Pharmaceutical Association; 1998